Gitay Kryger
Impact in
- Pharmacology top 0.2%
- Cholinesterase and Neurodegenerative Diseases
- Computational Theory and Mathematics top 0.5%
- Computational Drug Discovery Methods
Papers in
-
- Biochemical and Molecular Research 4
- Enzyme function and inhibition 4
- Protein Structure and Dynamics 4
-
- Cholinesterase and Neurodegenerative Diseases 8
- Co-authors
- Israel Silman (10 shared papers)Joel L. Sussman (10 shared papers)Michal Harel (4 shared papers)Harry M. Greenblatt (3 shared papers)T. Lewis (1 shared paper)Martin H. Weik (2 shared papers)Piet Gros (2 shared papers)Dov Barak (2 shared papers)
- Journals
- Journal of Molecular Biology (5 papers)Biochemistry (2 papers)Journal of Medicinal Chemistry (1 paper)Gene (1 paper)FEBS Letters (1 paper)
- Partner nations
- United StatesIsraelNetherlands
In The Last Decade
Gitay Kryger
16 papers receiving 2.5k citations
Gitay Kryger's Hit Papers
Peers
Comparison fields: 5 of 115
- Pharmacology 1.5k
- Computational Theory and Mathematics 1.0k
- Structural Biology 40
- Organic Chemistry 774
- Complementary and alternative medicine 128
Countries citing papers authored by Gitay Kryger
This map shows the geographic impact of Gitay Kryger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gitay Kryger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gitay Kryger more than expected).
Fields of papers citing papers by Gitay Kryger
This network shows the impact of papers produced by Gitay Kryger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gitay Kryger. The network helps show where Gitay Kryger may publish in the future.
Co-authors
The 25 scholars most cited alongside Gitay Kryger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Structure of acetylcholinesterase complexed with E2020 (Aricept®): implications for the design of new anti-Alzheimer drugs Hit paper breakdown → | 1999 | 649 |
| 2 | 2000 | 375 | |
| 3 | 2000 | 264 | |
| 4 | 2000 | 263 | |
| 5 | 1999 | 260 | |
| 6 | 1999 | 215 | |
| 7 | 2000 | 130 | |
| 8 | 1997 | 125 | |
| 9 | 1998 | 93 | |
| 10 | 1999 | 61 | |
| 11 | 2001 | 49 | |
| 12 | 2001 | 47 | |
| 13 | 2001 | 46 | |
| 14 | 1992 | 3 | |
| 15 | 1995 | 3 | |
| 16 | 1994 | 2 |
About Gitay Kryger
Gitay Kryger is a scholar working on Molecular Biology, Pharmacology, Materials Chemistry, Computational Theory and Mathematics and Organic Chemistry, having authored 16 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (8 papers), Enzyme Structure and Function (7 papers), Computational Drug Discovery Methods (6 papers), Biochemical and Molecular Research (4 papers), Enzyme function and inhibition (4 papers), Protein Structure and Dynamics (4 papers), Chemical synthesis and alkaloids (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). The work is most often cited by research in Pharmacology (1.5k citations), Computational Theory and Mathematics (1.0k citations), Structural Biology (40 citations), Organic Chemistry (774 citations) and Complementary and alternative medicine (128 citations). Gitay Kryger has collaborated with scholars based in United States, Israel and Netherlands. Frequent co-authors include Israel Silman, Joel L. Sussman, Michal Harel, Harry M. Greenblatt, T. Lewis, Martin H. Weik, Piet Gros, Dov Barak, Avigdor Shafferman and Charles B. Millard. Their work appears in journals such as Journal of Molecular Biology, Biochemistry, Journal of Medicinal Chemistry, Gene and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.